# The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty

> **NCT03795649** · NA · UNKNOWN · sponsor: **Sisters of Mercy University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Hemorrhage

## Interventions

- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT03795649
- **Lead sponsor:** Sisters of Mercy University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-18
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2019-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03795649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03795649, "The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03795649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*